Silo Pharma (SILO) Total Current Liabilities (2019 - 2025)
Silo Pharma (SILO) has disclosed Total Current Liabilities for 7 consecutive years, with $650183.0 as the latest value for Q4 2025.
- Quarterly Total Current Liabilities fell 60.74% to $650183.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $650183.0 through Dec 2025, down 60.74% year-over-year, with the annual reading at $650183.0 for FY2025, 60.74% down from the prior year.
- Total Current Liabilities hit $650183.0 in Q4 2025 for Silo Pharma, down from $708339.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.7 million in Q4 2024 to a low of $264135.0 in Q2 2021.
- Historically, Total Current Liabilities has averaged $723634.6 across 5 years, with a median of $693555.0 in 2023.
- Biggest five-year swings in Total Current Liabilities: skyrocketed 316.67% in 2023 and later tumbled 60.74% in 2025.
- Year by year, Total Current Liabilities stood at $490039.0 in 2021, then fell by 10.96% to $436318.0 in 2022, then surged by 77.76% to $775590.0 in 2023, then skyrocketed by 113.51% to $1.7 million in 2024, then crashed by 60.74% to $650183.0 in 2025.
- Business Quant data shows Total Current Liabilities for SILO at $650183.0 in Q4 2025, $708339.0 in Q3 2025, and $1.0 million in Q2 2025.